2019. IMMUNE CHECKPOINT INHIBITOR SALVAGE THERAPY IN PATIENT WITH REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA. Voprosy onkologii. 65, 2 (Feb. 2019), 294–297. DOI:https://doi.org/10.37469/0507-3758-2019-65-2-294-297.